CONGRESS FOR VOTERS

Jeanne Shaheen (D-NH)

INSULIN Act of 2026

S. 4189 · Senate bill Health

A Democratic bill with 14 Republican cosponsors · See all 28 cosponsors

Last activity — Placed on Senate Legislative Calendar under General Orders. Calendar No. 552.

Cleared committee, waiting for its first floor vote

A committee approved it and it is on the calendar of the chamber it started in.

This is further than most bills get, and still no promise of a vote: the calendar is a queue, and the majority leadership decides what is called. A bill can sit here until the Congress ends.

Its path through Congress

  1. Introduced
  2. On Calendar

What this bill would do

This bill, known as the "INSULIN Act of 2026," aims to lower insulin costs and increase patient protections. It requires group health plans and insurance issuers to cap cost-sharing for selected insulin products at $35 per 30-day supply. The legislation also mandates that pharmacy benefit managers pass 100 percent of insulin-related rebates back to health plans. Additionally, it establishes a pilot program and a resource center to assist uninsured individuals in accessing affordable insulin. Finally, the bill seeks to increase competition by expediting the review of biosimilar products and ensuring more timely access to generics.

Yes· 3 of 7

  • Scored +9

    Does this lower the price of prescription medicines?

    The bill caps insulin cost-sharing at $35 and mandates the pass-through of pharmacy rebates to health plans.

  • Scored +8

    Would households on low incomes be better off under this?

    The bill significantly reduces out-of-pocket costs for insulin through caps and assistance programs.

  • Scored +7

    Does this give people more protection from unfair business practices?

    The bill mandates insulin cost-sharing caps and prohibits certain medical management requirements to protect patients.

The opposite

No question was scored the opposite.